Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer

R. Saito, R. Shirakawa, H. Nishiyama, T. Kobayashi, M. Kawato, T. Kanno, K. Nishizawa, Y. Matsui, T. Ohbayashi, M. Horiguchi, T. Nakamura, T. Ikeda, K. Yamane, E. Nakayama, E. Nakamura, Y. Toda, T. Kimura, T. Kita, O. Ogawa, H. Horiuchi

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

The small GTPase Ral is known to be highly activated in several human cancers, such as bladder, colon and pancreas cancers. It is reported that activated Ral is involved in cell proliferation, migration and metastasis of bladder cancer. This protein is activated by Ral guanine nucleotide exchange factors (RalGEFs) and inactivated by Ral GTPase-activating proteins (RalGAPs), the latter of which consist of heterodimers containing a catalytic α1 or α2 subunit and a common β subunit. In Ras-driven cancers, such as pancreas and colon cancers, constitutively active Ras mutant activates Ral through interaction with RalGEFs, which contain the Ras association domain. However, little is known with regard to the mechanism that governs aberrant activation of Ral in bladder cancer, in which Ras mutations are relatively infrequent. Here, we show that Ral was highly activated in invasive bladder cancer cells due to reduced expression of RalGAPα2, the dominant catalytic subunit in bladder, rather than increased expression of RalGEFs. Exogenous expression of wild-type RalGAPα2 in KU7 bladder cancer cells with invasive phenotype, but not mutant RalGAPα2-N1742K lacking RalGAP activity, resulted in attenuated cell migration in vitro and lung metastasis in vivo. Furthermore, genetic ablation of Ralgapa2 promoted tumor invasion in a chemically-induced murine bladder cancer model. Importantly, immunohistochemical analysis of human bladder cancer specimens revealed that lower expression of RalGAPα2 was associated with advanced clinical stage and poor survival of patients. Collectively, these results are highly indicative that attenuated expression of RalGAPα2 leads to disease progression of bladder cancer through enhancement of Ral activity.

Original languageEnglish
Pages (from-to)894-902
Number of pages9
JournalOncogene
Volume32
Issue number7
DOIs
Publication statusPublished - 2013 Feb 14

Keywords

  • Ral small GTPase
  • RalGAPα2
  • bladder cancer
  • invasion
  • metastasis

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Fingerprint Dive into the research topics of 'Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer'. Together they form a unique fingerprint.

  • Cite this

    Saito, R., Shirakawa, R., Nishiyama, H., Kobayashi, T., Kawato, M., Kanno, T., Nishizawa, K., Matsui, Y., Ohbayashi, T., Horiguchi, M., Nakamura, T., Ikeda, T., Yamane, K., Nakayama, E., Nakamura, E., Toda, Y., Kimura, T., Kita, T., Ogawa, O., & Horiuchi, H. (2013). Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer. Oncogene, 32(7), 894-902. https://doi.org/10.1038/onc.2012.101